Table 1.
Co-localization coefficient of inflammasome proteins.
Pearson’s co-localization coefficient (PCC) of NLRP1 and NLRP3 with PYCARD, caspase-1, caspase-5 and caspase-8, in LPS-primed and Aβ42−stimulated CD14+ monocyte of patients with a diagnosis of either severe or moderate (MILD) Alzheimer’s Disease (AD) and mild cognitive impairment (MCI). Result obtained in and in age-and sex-matched healthy controls (HC) are also shown. Index reference values: PC range= −1 and +1
PCC | severe AD | MILD AD | MCI | HC |
---|---|---|---|---|
NLRP1+ PYCARD + | 0.8ac (0.7-0.82) | 0.8 de (0.7-0.82) | 0.5ad (0.3-0.6) | 0.4ce (0.3–0.5) |
NLRP1+ CASPASE-1+ | 0.6 (0.4-0.7) | 0.8 (0.7-0.84) | 0.6 (0.4-0.65) | 0.5 (0.5-0.7) |
NLRP1+ CASPASE-5+ | 0.7bac (0.5–0.8) | 0.4b (0.23-0.5) | 0.3a (0.1-0.32) | 0.3c (0.2-0.5) |
NLRP3+ PYCARD + | 0.8ac (0.6-0.82) | 0.8 de (0.7-0.82) | 0.6ad (0.5-0.7) | 0.5ce (0.4-0.6) |
NLRP3+ CASPASE-1+ | 0.9bac (0.8-0.9) | 0.8bde (0.5-0.8) | 0.5ad (0.4-0.56) | 0.3ce (0.3-0.4) |
NLRP3+ CASPASE-8+ | 0.8ac (0.7-0.85) | 0.6 (0.5-0.72) | 0.5a (0.3-0.55) | 0.5c (0.3-0.6) |
Median values, interquartile range and statistical significances are presented (p <0.05)
aAD vs. MCI
bAD vs. MILD AD
cAD vs. HC
dMILD AD vs. MCI
eMILD AD vs. HC